Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Dow
Mallinckrodt
Harvard Business School
Boehringer Ingelheim

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Litigation Details for Natural Alternatives International, Inc. v. Woodbolt Distribution, LLC (S.D. Tex. 2011)

See Plans and Pricing

« Back to Dashboard

Natural Alternatives International, Inc. v. Woodbolt Distribution, LLC (S.D. Tex. 2011)

Docket   Start Trial Date Filed 2011-12-21
Court District Court, S.D. Texas Date Terminated 2016-03-19
Cause 35:271 Patent Infringement Assigned To Lynn Nettleton Hughes
Jury Demand Both Referred To
Parties BODYBUILDING.COM LLC; F.H.G. CORPORATION; F.H.G. CORPORATION, D/B/A INTEGRITY NUTRACEUTICALS; GNC CORPORATION; NATURAL ALTERNATIVES INTERNATIONAL, INC.; VITAQUEST INTERNATIONAL, INC.; VITAQUEST INTERNATIONAL, INC., D/B/A GARDEN STATE NUTRITIONALS; WOODBOLT DISTRIBUTION, LLC; WOODBOLT DISTRIBUTION, LLC, ALSO KNOWN AS CELLUCOR
Patents 5,250,534; 6,469,012
Attorneys Arianna Frankl; Barry L Evans; C Dale Quisenberry; Caroline Cook Maxwell; Damon T Kamvosoulis; David Kohane; Emily S Chou; Glenn A Ballard , Jr; Jayme Partridge; Jeffrey Scott David; John T Polasek; Kevin M Bell; Lacy L Kolo; Mark D Schneider; Paul Andrew Dyson; Peter J Phillips; Richard J Oparil; Scott Allen Max Chambers
Firms Cole Schotz; Cole Schotz Et Al; Gifford Krass Et Al; Polasek Quisenberry Et Al; Susman Godfrey LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Natural Alternatives International, Inc. v. Woodbolt Distribution, LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Natural Alternatives International, Inc. v. Woodbolt Distribution, LLC (S.D. Tex. 2011)

Date Filed Document No. Description Snippet Link To Document
2012-09-06 72 Supplement pressure and treat angina. U.S. Patent No. 5,250,534 (“the ‘534 patent”) claimed the composition of matter…the ‘381 patent and Claims 13 and 14 in the ‘422 patent). These new combinations are patentably distinct…MOTION for Summary Judgment OF PATENT INVALIDITY OF PLAINTIFFS U.S. PATENTS NOS. 8,067,381 AND 8,129,422…Supplement Patents The Court asked whether beta-alanine could be the subject of a patent because …because the patent holder made a showing of likelihood of success that patents External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Moodys
Merck
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.